VCM
LLY icon

Valiant Capital Management’s Eli Lilly LLY Stock Holding History

Valiant Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.3M Sell
24,286
-2,240
-8% -$2.27M 1.28% 24
2025
Q4 		$28.5M Sell
26,526
-13,691
-34% -$13.1M 1.61% 23
2025
Q3 		$30.7M Sell
40,217
-11,709
-23% -$8.71M 2.11% 18
2025
Q2 		$40.5M Buy
51,926
+31,300
+152% +$24.3M 2.22% 17
2025
Q1 		$17M Hold
20,626
– – 1.25% 28
2024
Q4 		$15.9M Sell
20,626
-8,900
-30% -$7.37M 1.01% 25
2024
Q3 		$26.2M Sell
29,526
-16,534
-36% -$14.9M 1.44% 21
2024
Q2 		$41.7M Sell
46,060
-2,040
-4% -$1.63M 2.22% 14
2024
Q1 		$37.4M Hold
48,100
– – 2.37% 13
2023
Q4 		$28M Buy
48,100
+10,500
+28% +$6.13M 1.37% 19
2023
Q3 		$20.2M Buy
+37,600
New +$19.4M 1.94% 18

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Valiant Capital Management's LLY Position: Q1 2026 in Review

Valiant Capital Management reduced its Eli Lilly (LLY) stake by 8.4% in Q1 2026, selling an estimated $2.27M and leaving 24,286 shares worth $22.3M. The position accounts for 1.28% of the portfolio, ranked #24.

Valiant Capital Management first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $41.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Valiant Capital Management held 24,286 shares of Eli Lilly worth $22.3M as of Q1 2026.
  • Valiant Capital Management sold 2,240 Eli Lilly shares in Q1 2026, an estimated $2.27M.
  • Eli Lilly made up 1.28% of Valiant Capital Management's portfolio in Q1 2026, its #24 holding.
  • Valiant Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Valiant Capital Management's Eli Lilly position peaked at $41.7M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Valiant Capital Management's 13F filing for Q1 2026, filed 15 May 2026.